SS

Satish Sadanand Talwadker

Director Director DIN 00044965
DIN 00044965 First appointment Sep 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2001
Shareholding value •••• Premium profile

About Satish Sadanand Talwadker

Data last updated:

Satish Sadanand Talwadker was a Director at Geno Pharmaceuticals Private Limited (2008–2023) and Director at Clin Medicals Private Limited (2001–2014). The companies operate in Pharma and Home Appliances.

DIN 00044965
Primary Designation Director
Industry Pharma
First Appointment 29 Sep 2001

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Geno Pharmaceuticals Private Limited U24239GA1975PTC000250
Director27 Mar 20081975₹349 Cr (FY 2025)Active
Clin Medicals Private Limited U52311GA1995PTC001881
Director29 Sep 20011995Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Geno Pharmaceuticals Private Limited
Clin Medicals Private Limited
Premium access

Shareholding and investment profile for Satish Sadanand Talwadker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satish Sadanand Talwadker

Satish Sadanand Talwadker was first appointed on 29 Sep 2001 as Director at Clin Medicals Private Limited. The most recent appointment on record is 27 Mar 2008 at Geno Pharmaceuticals Private Limited.

Satish Sadanand Talwadker held 2 earlier board appointments: Geno Pharmaceuticals Private Limited (Director, 27 Mar 2008 to 01 Apr 2023); Clin Medicals Private Limited (Director, 29 Sep 2001 to 14 Feb 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available